Trades on 1 secondary market

Cerevance

Cerevance is a clinical-stage biopharmaceutical company developing novel therapeutics for central nervous system (CNS) disorders. Its proprietary NETSseq platform profiles gene expression across specific human brain cell types from post-mortem tissue to identify previously undiscovered, cell-type-sp

emerging 15.0 / 100 0 APIs View provider profile →

Company Life Sciences Biotechnology Pharmaceuticals Drug Discovery Central Nervous System

Cerevance is an API provider whose private shares are listed on 1 secondary market: EquityZen.

Where It Trades

EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.